Guardant Health (GH) Change in Receivables (2017 - 2026)

Guardant Health has disclosed Change in Receivables across 10 years of filings, most recently posting -$942000.0 for Q1 2026.

• Change in Receivables for Q1 2026 came in at -$942000.0, down 115.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.1 million (down 33.43% YoY), and the FY2025 annual result was $28.2 million, up 31.73% from the prior year.
• Change in Receivables came in at -$942000.0 for Q1 2026 at Guardant Health, down from $22.2 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $22.2 million in Q4 2025 to a low of -$14.5 million in Q3 2025.
• The 5-year median for Change in Receivables is $1.7 million (2023), against an average of $2.3 million.
• Peak annual rise in Change in Receivables reached 120683.33% in 2024, while the deepest fall reached 616.19% in 2024.
• Guardant Health's Change in Receivables stood at $11.1 million in 2022, then plunged by 100.16% to -$18000.0 in 2023, then surged by 120683.33% to $21.7 million in 2024, then grew by 2.3% to $22.2 million in 2025, then plunged by 104.24% to -$942000.0 in 2026.
• The last three Change in Receivables figures came in at -$942000.0 (Q1 2026), $22.2 million (Q4 2025), and -$14.5 million (Q3 2025), per Business Quant data.